Selected data models

You must log in to select data models for download or further analysis.

4 Search results.
Relevance Rating New first Old first

EWOG MDS 2006 Severe complications till day +100 DRKS00003789 - Severe complications till day +100

- 8/5/14 - 1 form, 10 itemgroups, 20 items, 2 languages
Itemgroups: Show identification of patient, Severe infection occurred, Severe pulmonary complications, Severe cardio-vascular complications, Severe renal complications, Severe hepatic complications, VOD, Severe neurological complications, Severe gastrointestinal complications, Other severe complications
Prospective non–randomized multi​center study for epidemiology and characterization of Myelodysplastic Syndromes(MDS) and Juvenile Myelomonocytic Leukemia (JMML) in child­hood. PI: Prof. Dr. Charlotte Niemeyer http://clinicaltrials.gov/ct2/show/NCT00662090 http://www.ewog-mds.org/

EWOG MDS 2006 Severe complications after day 100 DRKS00003789 - Severe complications after day 100

- 8/5/14 - 1 form, 11 itemgroups, 24 items, 2 languages
Itemgroups: Show identification of patient, Severe infection occurred, Severe pulmonary complications, Severe cardio-vascular complications, Severe renal complications, Severe hepatic complications, Severe neurological complications, Severe gastrointestinal complications, Severe endocrinologic complications, Severe sceletal complications, Other severe complications
Prospective non–randomized multi​center study for epidemiology and characterization of Myelodysplastic Syndromes(MDS) and Juvenile Myelomonocytic Leukemia (JMML) in child­hood. PI: Prof. Dr. Charlotte Niemeyer http://clinicaltrials.gov/ct2/show/NCT00662090 http://www.ewog-mds.org/

EWOG MDS 2006 Status Day 30 DRKS00003789 - Status Day 30

- 8/5/14 - 1 form, 15 itemgroups, 57 items, 2 languages
Itemgroups: Show identification of patient, Complications - Infection, Complications - EBV PCR, Complications - EBV LPD, Complications - EBV LPD symptoms, Complications - EBV LPD site, Complications - EBV LPD treatment, Complications - Hemorrhage, Complications - Renal/Metabolic Lab., Creatinine, Complications - Other type of complication, Transfusions, Transfusion PLT, Transfusion RBC, Complete blood count, Study centre specific variables
Prospective non–randomized multi​center study for epidemiology and characterization of Myelodysplastic Syndromes(MDS) and Juvenile Myelomonocytic Leukemia (JMML) in child­hood. PI: Prof. Dr. Charlotte Niemeyer http://clinicaltrials.gov/ct2/show/NCT00662090 http://www.ewog-mds.org/

EWOG MDS 2006 IST FUP {0} DRKS00003789 - IST FUP {0}

- 8/5/14 - 1 form, 21 itemgroups, 82 items, 2 languages
Itemgroups: Show identification of patient, IST FUP, Immunosuppressive Therapy - Steroids in given interval, Immunosuppressive Therapy - Cyclosporin A, Immunosuppressive Therapy - Cyclosporin A, Immunosuppressive Therapy - G-CSF, Complications - Infection, Complications - EBV PCR, Complications - EBV LPD, Complications - EBV LPD symptoms, Complications - EBV LPD site, Complications - EBV LPD treatment, Complications - Hemorrhage, Complications - Renal/Metabolic Lab., Creatinine, Complications - Other type of complication, Response - Transfusions, Response - Transfusion PLT, Response - Transfusion RBC, Response - Complete blood count, Response, Study centre specific variables
Prospective non–randomized multi​center study for epidemiology and characterization of Myelodysplastic Syndromes(MDS) and Juvenile Myelomonocytic Leukemia (JMML) in child­hood. PI: Prof. Dr. Charlotte Niemeyer http://clinicaltrials.gov/ct2/show/NCT00662090 http://www.ewog-mds.org/

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial